Healthy subjects
Conditions
Interventions
Single ingestion of the test food >
Single ingestion of the placebo food
Single ingestion of the placebo food >
Sponsors
Morinaga & Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Healthy male/female subjects ranging in age from 18 to 39, at informed consent. (2)Subjects who can give informed consent to participate in this trial, after being provided with an explanation of the protocol detail. (3)Subjects who can visit the designated measurement days and receive the measurement.
Exclusion criteria
Exclusion criteria: Subjects 1) who have a habit of continuously taking drugs, foods with health claims (Foods with Nutritional Function Claims, Foods for Specified Health Uses, and Foods with Function Claims), health foods, or supplements that claim to maintain or promote cognitive function (At least 3 times/week for at least 1 month), currently or within the past 3 months, or those who plan to take them during the study period 2) whose sleeping timeframe fluctuate greatly, such as shift work 3) who may change their lifestyle habits during the study period (Changing jobs, moving, long trips, learning, etc.) 4) being under another clinical test with medicine or health food, or partook in that within the past 4 weeks, or will partake in another clinical test 5) who may take medicine during the study period due to seasonal allergies (e.g., hay fever) 6) having a habit of smoking 7) with excessive alcohol intake 8) with lifestyle diseases (e.g., diabetes mellitus, hypertension, dyslipidemia) or diagnosed in the past 9) who has been diagnosed as having hyperglycemia through a medical examination 10) with neurological disorders such as dementia, stroke, Parkinson's disease, epilepsy, etc. (Excluding headaches and migraines) 11) who received medication for 1 month prior to obtaining consent or who plan to receive medication during the study period (Excluding history of taking medicine for headache, menstrual pain, cold, etc.) 12) with a past or current history of serious diseases (e.g., heart disease, cancer, renal failure) 13) who are pregnant, lactating or planning to become a pregnant during the study period 14) with sensitive skin to any coatings (e.g., drugs, quasi drugs, cosmetics), bath salts, tapes, etc., and those with wounds on the head (forehead, near mastoid process (behind ear)) 15) with allergies to drug and/or food (including a history of these allergies) (especially milk and gelatin) 16) deemed unsuitable for participation in the trial by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitrax | — |
Secondary
| Measure | Time frame |
|---|---|
| Electroencephalogram, Visual analog scale questionnaire | — |
Countries
Japan
Contacts
Public ContactYuko Setoguchi
Morinaga & Co., Ltd. Health Science and Research Center, R&D institute
Outcome results
None listed